Exchange Bulletin

Titan Medical Inc. (TMD.WT.E) To Trade On Toronto Stock Exchange


May 7, 2014

TITAN MEDICAL INC. ("TMD") ("TMD.WT.E")
BULLETIN TYPE: New Listing-Warrants
BULLETIN DATE: May 6, 2014
TSX Venture Tier 2 Company

Effective at the opening, Wednesday, May 7, 2014, the warrants of the Company
will commence trading on TSX Venture Exchange. The Company is classified as a
'Medical Devices Manufacturing' company.

Corporate Jurisdiction: Ontario

Capitalization: 12,203,189 Warrants with no par value of which
12,203,189 are issued and outstanding

Transfer Agent: Olympia Transfer Services Inc.
Trading Symbol: TMD.WT.E
CUSIP Number: 88830X199

The Warrants were issued pursuant to a Prospectus Offering of 12,203,189 Units
(10,611,469 Units plus over-allotment option for an additional 1,591,720 units)
at $2.10 per Unit with 12,203,189 Warrants. Each Warrant entitles the holder
to purchase one common share at a price of $2.75 per common share and will
expire on Sunday, April 23, 2017.

An additional 699,190 Broker Warrants were issued pursuant to the Company's
Prospectus Offering (accepted by the Exchange May 5, 2014). As of the date
hereof, zero (0) Broker Warrants have been exercised. Up to an additional
699,190 Warrants could be added to the current Warrants issued and outstanding
in the event the Agent from the Company's Prospectus Offering exercises its
Broker Warrants. See below for information regarding the Broker Warrants from
the Prospectus Offering.

Agent's Fee: Excluding the sale of Units issued to subscribers identified by
the company via a 'President's List' (for up to 5% of the gross proceeds raised
through the sale of Units), the Agent shall receive a fee equal to 6% of the
proceeds from Units sold pursuant to the agency agreement between the Company
and the Agent. Proceeds raised through the sale of Units to subscribers on the
President's List are subject to a commission of 3%. In addition the Company
will issue to the Agent compensation warrants ("Broker Warrants") to purchase
such number of Units equal to 6% (699,190 Units) of the number of Units sold
(but excluding those Units issued to subscribers on the President's List).
Each Broker Warrant is exercisable into one common share and one Warrant at a
price of $2.10 for a period of two years following closing of the Offering.
Each subsequent Warrant issued on exercise of the Broker Warrant is exercisable
into one common share at a price of $2.75 for a period of three years following
closing of the Offering.